Small datasets to develop and validate prognostic models may be a necessary evil to study rare tumours
Sara Valpione1, Simone Mocellin2, Luca Giovanni Campana2
1The Christie Foundation Trust, Wilmslow Rd, Manchester, M20 4BX, United Kingdom; Department of Surgery, Oncology and Gastroenterology, University of Padova, 64 Gattamelata St, 35128, Padova, Italy.
Summary
No abstract available in PubMed .
Related Concept Videos
Cancer Survival Analysis
823
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
823
Tumor Progression
7.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K


